Get the Stockscreener App
1.85
5.56%
-0.13
After Hours:
1.85
Entera Bio Ltd Stock (ENTX) Forecast
The Entera Bio Ltd (ENTX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.7377, representing a -60.13% decrease from the current price of $1.85. The highest analyst price target is $1.422, and the lowest is $0.0534.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ENTX Price Target
Average 0.7413
(-59.93% Downside)
Is Entera Bio Ltd (ENTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 40.63 | Neutral |
| STOCH(9,6) | 39.45 | Neutral |
| STOCHRSI(14) | 51.43 | Neutral |
| MACD(12,26) | -0.1015 | Sell |
| ADX(14) | 29.50 | Sell |
| William %R | -80.56 | Buy |
| CCI(14) | -18.65 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.913
Sell
|
1.9473
Sell
|
| MA20 |
2.0472
Sell
|
2.0289
Sell
|
| MA50 |
2.2467
Sell
|
2.1176
Sell
|
| MA100 |
2.0574
Sell
|
2.0767
Sell
|
| MA200 |
1.9578
Sell
|
1.9097
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ENTX could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on ENTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 40.63 indicates that ENTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 39.45 indicates that ENTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 51.43 indicates that ENTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.5 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -18.65 indicates that ENTX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ENTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Entera Bio Ltd financial reports and earnings history, Entera Bio Ltd (ENTX) stock could reach $0.638 by 2030, $2.8987 by 2040 and $5.3484 by 2050. See the projected annual prices until 2050 of the Entera Bio Ltd stock below:
- Entera Bio Ltd (ENTX) is expected to reach an average price of $1.5537 in 2035, with a high prediction of $1.5829 and a low estimate of $1.5637. This indicates an $-16.02% rise from the last recorded price of $1.85.
- Entera Bio Ltd (ENTX) stock is projected to chart a bullish course in 2040, with an average price target of $2.9837, representing an $61.28% surge from its current level. The forecast ranges from a conservative $2.9261 to a sky-high $2.8987.
- Our analysts predict Entera Bio Ltd (ENTX) to jump 140.42% by 2045, soaring from $4.2517 to an average price of $4.4478, potentially reaching $4.3378. While $4.2517 is the low estimate, the potential upside is significant.
- Entera Bio Ltd (ENTX) stock is expected to climb by 2050, reaching an average of $4.9734, a $168.83% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.3484 and $5.3572, respectively, highlighting the market's uncertainty.
Entera Bio Ltd Stock (ENTX) Year by Year Forecast
Entera Bio Ltd Stock (ENTX) Price Forecast for 2025
Entera Bio Ltd Stock (ENTX) is expected to reach an average price of $0.7357 in 2025, with a high prediction of $1.4595 and a low estimate of $0.012. This indicates an -60.23% fall from the last recorded price of $1.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $0.1446 | $0.0534 | $1.422 | -92.18% |
| May, 2025 | $0.0632 | $0.1098 | $0.5476 | -96.58% |
| June, 2025 | $0.3459 | $0.0349 | $0.5159 | -81.31% |
| July, 2025 | $0.00585 | $0.0232 | $1.4595 | -99.68% |
| August, 2025 | $0.0912 | $0.0422 | $0.2238 | -95.07% |
| September, 2025 | $0.1466 | $0.0361 | $1.3661 | -92.08% |
| October, 2025 | $0.7483 | $0.4329 | $0.5183 | -59.55% |
| November, 2025 | $0.5637 | $0.5637 | $0.6646 | -69.53% |
| December, 2025 | $0.7454 | $0.59 | $0.649 | -59.71% |
Entera Bio Ltd Stock (ENTX) Price Forecast for 2026
The predicted value for Entera Bio Ltd (ENTX) in 2026 is set at an average of $4.2573. Estimates vary from a peak of $8.4478 to a trough of $0.0668, indicating an +130.13% surge from the present price of $1.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.7107 | $0.7411 | $0.6707 | -61.58% |
| February, 2026 | $0.6961 | $0.6834 | $0.6661 | -62.37% |
| March, 2026 | $0.4515 | $0.5615 | $0.6624 | -75.60% |
| April, 2026 | $0.1668 | $0.0668 | $0.5232 | -90.98% |
| May, 2026 | $2.8615 | $0.1595 | $8.4478 | +54.67% |
| June, 2026 | $1.8061 | $1.5188 | $3.6251 | -2.37% |
| July, 2026 | $1.2544 | $1.1334 | $2.3843 | -32.20% |
| August, 2026 | $2.139 | $1.228 | $2.639 | +15.62% |
| September, 2026 | $4.2573 | $2.0127 | $7.0263 | +130.13% |
| October, 2026 | $3.352 | $3.112 | $4.281 | +81.19% |
| November, 2026 | $3.2666 | $2.7294 | $4.2156 | +76.57% |
| December, 2026 | $3.0649 | $2.8176 | $3.7802 | +65.67% |
Entera Bio Ltd Stock (ENTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Entera Bio Ltd (ENTX) is $1.6982, with a high forecast of $3.3922 and a low forecast of $0.00415. This indicates an -8.21% decrease from the last price of $1.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.7195 | $2.5195 | $3.3922 | +47.00% |
| February, 2027 | $1.9541 | $1.7041 | $2.7732 | +5.63% |
| March, 2027 | $1.6024 | $1.3161 | $2.1578 | -13.38% |
| April, 2027 | $1.2971 | $1.0634 | $1.9701 | -29.89% |
| May, 2027 | $0.7817 | $0.5944 | $1.3907 | -57.75% |
| June, 2027 | $0.65 | $0.2127 | $0.9253 | -64.86% |
| July, 2027 | $1.3846 | $0.5519 | $1.481 | -25.15% |
| August, 2027 | $1.2193 | $0.8266 | $1.5293 | -34.09% |
| September, 2027 | $0.7776 | $0.3902 | $1.4329 | -57.97% |
| October, 2027 | $0.2322 | $0.1722 | $0.9385 | -87.45% |
| November, 2027 | $0.0568 | $0.00415 | $0.2595 | -96.93% |
| December, 2027 | $0.4151 | $0.0259 | $0.5878 | -77.56% |
Entera Bio Ltd Stock (ENTX) Price Forecast for 2028
In 2028, Entera Bio Ltd (ENTX) is projected to reach an average price of $0.3428, with a high projection of $0.648 and a low estimate of $0.0376. This indicates an -81.47% fall from the last price of $1.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.00976 | $0.0376 | $0.4688 | -99.47% |
| February, 2028 | $0.3356 | $0.0866 | $0.1837 | -81.86% |
| March, 2028 | $0.5748 | $0.412 | $0.5623 | -68.93% |
| April, 2028 | $0.6335 | $0.6925 | $0.6463 | -65.76% |
| May, 2028 | $0.7743 | $0.6732 | $0.648 | -58.15% |
| June, 2028 | $0.4288 | $0.4898 | $0.5808 | -76.82% |
| July, 2028 | $0.3851 | $0.4188 | $0.3325 | -79.18% |
| August, 2028 | $0.1268 | $0.2168 | $0.3415 | -93.14% |
| September, 2028 | $0.4012 | $0.259 | $0.1695 | -78.31% |
| October, 2028 | $0.4275 | $0.4283 | $0.3962 | -76.89% |
| November, 2028 | $0.3418 | $0.3602 | $0.403 | -81.53% |
| December, 2028 | $0.3712 | $0.4046 | $0.3683 | -79.93% |
Entera Bio Ltd Stock (ENTX) Price Forecast for 2029
The 2029 price forecast for Entera Bio Ltd Stock (ENTX) is $1.1878 on average, with a high prediction of $2.3073 and a low estimate of $0.0683. This represents an -35.79% decrease from the previous price of $1.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.4033 | $0.401 | $0.36 | -78.20% |
| February, 2029 | $0.4957 | $0.4427 | $0.4217 | -73.21% |
| March, 2029 | $0.4821 | $0.5234 | $0.4807 | -73.94% |
| April, 2029 | $0.4224 | $0.4924 | $0.4348 | -77.17% |
| May, 2029 | $0.4341 | $0.4865 | $0.4415 | -76.53% |
| June, 2029 | $0.4641 | $0.4368 | $0.4166 | -74.91% |
| July, 2029 | $0.5049 | $0.4654 | $0.4122 | -72.71% |
| August, 2029 | $0.2462 | $0.1628 | $0.408 | -86.69% |
| September, 2029 | $0.022 | $0.1267 | $0.2425 | -98.81% |
| October, 2029 | $0.5263 | $0.0683 | $0.809 | -71.55% |
| November, 2029 | $0.951 | $0.40 | $2.3073 | -48.60% |
| December, 2029 | $0.10 | $0.382 | $1.2221 | -94.59% |
Entera Bio Ltd Stock (ENTX) Price Forecast for 2030
Entera Bio Ltd Stock (ENTX) is expected to reach an average price of $1.0425 in 2030, with a high forecast of $1.7893 and a low forecast of $0.2957. This signifies an -43.65% decrease from the last price of $1.85.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.2934 | $0.2957 | $0.638 | -84.14% |
| February, 2030 | $0.8841 | $0.8761 | $0.8841 | -52.21% |
| March, 2030 | $1.1949 | $0.3795 | $0.6549 | -35.41% |
| April, 2030 | $1.4756 | $1.7829 | $1.2756 | -20.24% |
| May, 2030 | $1.549 | $1.5683 | $1.539 | -16.27% |
| June, 2030 | $1.3448 | $1.7117 | $1.5317 | -27.31% |
| July, 2030 | $1.6032 | $1.5651 | $1.5651 | -13.34% |
| August, 2030 | $1.9639 | $1.9359 | $1.6812 | +6.16% |
| September, 2030 | $1.1546 | $1.8246 | $1.7893 | -37.59% |
| October, 2030 | $0.728 | $0.792 | $1.0573 | -60.65% |
| November, 2030 | $1.3588 | $0.9707 | $0.9898 | -26.55% |
| December, 2030 | $2.0195 | $1.9668 | $1.7395 | +9.16% |
0.49%
1.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):